Malaysia Should Reject European Union Intellectual Property Demands that Prolong Monopolies and Increase Medicine Prices
OPEN LETTER Penang, 7 June 2026 – Civil society organizations have warned the Malaysian Government that intellectual property (IP) proposals being tabled by the European Union (EU) will weaken Malaysia’s generic industry, undermine competition and increase prices of pharmaceutical products in Malaysia. The fourth round of negotiations is expected to take place on 9-12 June 2026, according to...
Read More